000			02147 a2200649 4500
005			20250517065150.0
264		0	_c20180209
008			201802s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.5515 _2doi
040			_aNLM _beng _cNLM
100	1		_aHuang, Chu-Ying
245	0	0	_aBisphosphonates enhance EGFR-TKIs efficacy in advanced NSCLC patients with EGFR activating mutation: A retrospective study. _h[electronic resource]
260			_bOncotarget _cOct 2016
300			_a66480-66490 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBone Neoplasms _xdrug therapy
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCrown Ethers _xadministration & dosage
650	0	4	_aDiphosphonates _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aErbB Receptors _xantagonists & inhibitors
650	0	4	_aErlotinib Hydrochloride _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aGefitinib
650	0	4	_aHumans
650	0	4	_aImidazoles _xadministration & dosage
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMutation
650	0	4	_aPamidronate
650	0	4	_aProtein Kinase Inhibitors _xadministration & dosage
650	0	4	_aQuinazolines _xadministration & dosage
650	0	4	_aRetrospective Studies
650	0	4	_aTreatment Outcome
650	0	4	_aZoledronic Acid
700	1		_aWang, Li
700	1		_aFeng, Cheng-Jun
700	1		_aYu, Ping
700	1		_aCai, Xiao-Hong
700	1		_aYao, Wen-Xiu
700	1		_aXu, Yong
700	1		_aLiu, Xiao-Ke
700	1		_aZhu, Wen-Jiang
700	1		_aWang, Yan
700	1		_aZhou, Jin
700	1		_aLu, You
700	1		_aWang, Yong-Sheng
773	0		_tOncotarget _gvol. 7 _gno. 41 _gp. 66480-66490
856	4	0	_uhttps://doi.org/10.18632/oncotarget.5515 _zAvailable from publisher's website
999			_c25502806 _d25502806